EUVIMEDEUVIMED entdecken
Editorial

Intraductal Carcinoma of the Prostate as a Window Into PARP Inhibitor Sensitivity

Panagiotis J Vlachostergios

International Journal of Cancer · 03.11.2026

DOI: 10.1002/ijc.70809 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Cancer, online erschienen am 03.11.2026. Verfasst von Panagiotis J Vlachostergios. Beteiligte Einrichtung: Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece.
  • Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
  • Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Zitieren

APA

Vlachostergios, P. J. (2026). Intraductal Carcinoma of the Prostate as a Window Into PARP Inhibitor Sensitivity. International Journal of Cancer. https://doi.org/10.1002/ijc.70809

Vancouver

Vlachostergios PJ. Intraductal Carcinoma of the Prostate as a Window Into PARP Inhibitor Sensitivity. International Journal of Cancer. 2026. doi:10.1002/ijc.70809

BibTeX
@article{Vlachostergios2026,
  author = {Vlachostergios, Panagiotis J},
  title = {Intraductal Carcinoma of the Prostate as a Window Into PARP Inhibitor Sensitivity},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70809}
}
Kostenlos starten →